Our R&D strategy is to continue reinforcing therapeutic and other areas where we are already strong, while exploring and expanding across newer areas that we believe are set for innovation. Quality has been the cornerstone for Lumera as it has always endeavored to deliver services with a mark of excellence. The R&D facility at Axa Parenterals Ltd has been the nucleus of our activities and growth, thereby regularizing and accelerating the functioning and maintenance of higher quality standards through sustained innovation. Through our augmented R&D, we focus on developing services and technologies to strengthen the benefits of our core products.

We are equipped with a highly accomplished R&D facility managed by knowledgeable and dedicated scientists; assuring product quality assessment during product shelf life. The storage conditions are designed as per the International Guidelines to maintain quality standards.

Our capabilities include:

  • Formulation development
  • Analytical development
  • Microbiological testing
  • Stability studies
  • Regulatory affairs


Formulation Capabilities:

  • Ophthalmic solutions/ Suspensions -Multidose & Unitdose
  • Balanced Salt Solution in Euro head LDPE Large volume Bottles